| Literature DB >> 26107336 |
Abstract
Horner syndrome is typically described by the classic triad of blepharoptosis, miosis, and anhydrosis resulting from disruption along the oculosympathetic pathway. Because of the complex and extensive course of this pathway, there are a large number of causes of Horner syndrome ranging from benign to life-threatening diseases. This review article aims to provide a practical approach to investigation and management, including evaluation of the more recent use of apraclonidine for pharmacological testing.Entities:
Year: 2012 PMID: 26107336 DOI: 10.1097/APO.0b013e318256009d
Source DB: PubMed Journal: Asia Pac J Ophthalmol (Phila) ISSN: 2162-0989